To further investigate the clinical significance of FRMD8 in breast cancer patients, we performed immunohistochemical staining of FRMD8 in a tissue microarray of breast cancer patients and evaluated the level of FRMD8 (Figure 6F). Here, FRMD8 is linked to breast carcinoma.